PAR-4 as a possible new target for pancreatic cancer therapy.
PAR-4 as a possible new target for pancreatic cancer therapy.
复制标题
DOI:
10.1517/14728222.2010.487066
复制
发表时间:
2010-06
影响因子:
5.8
通讯作者:
Mohammad RM
中科院分区:
文献类型:
--
作者:
Azmi AS;Philip PA;Zafar SF;Sarkar FH;Mohammad RM
Pancreatic cancer (PC) is a deadly disease that is so far intractable to currently available treatment regimens. Although well described in different tumors types, the importance of apoptosis inducer Par-4 in PC has not been appreciated. PC is a oncogenic kras driven disease which is known to down-regulate Par-4. Therefore, this review highlights its significance and builds a strong case supporting the role of Par-4 as a possible therapeutic target in PC. This article covers literature based evidence spanning the last 15 years on Par-4 and its significance in PC. This review provides comprehensive knowledge of the significance of Par-4 and its association with kras status in PC, along with the crosstalk with crucial resistance and survival molecules NF-kB and Bcl-2 that ultimately are responsible for the overall poor outcome of different therapeutic approaches in this disease. Par-4 holds promise as a potential therapeutic target that can be induced by chemopreventive agents and small molecule inhibitors either alone or in combination with standard chemotherapeutics leading to selective apoptosis in PC cells. It also acts as a chemosensitizer and therefore warrants further clinical investigations in this deadly disease.
登录
查看更多内容
影响因子:
8
作者:
Ni Chonghaile T;Letai A
通讯作者:
Letai A
影响因子:
5.7
作者:
Ali, Shadan;Banerjee, Sanjeev;Sarkar, Fazlul H.
通讯作者:
Sarkar, Fazlul H.
影响因子:
4.8
作者:
Cheema, SK;Mishra, SK;Lopez-Berestein, G
通讯作者:
Lopez-Berestein, G
影响因子:
8.8
作者:
Bramhall, SR;Schulz, J;Nemunaitis, J;Brown, PD;Baillet, M;Buckels, JAC
通讯作者:
Buckels, JAC
影响因子:
3.6
作者:
Evans, JD;Cornford, PA;Neoptolemos, JP
通讯作者:
Neoptolemos, JP